Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | GPR88 | Q9GZN0 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 3/20 | 0.35 |
| ▸ | RAB9A | P51151 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | RARB | P10826 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6521140 | 0.86 | KMT2A (0.40) | SMN1; SMN2L3MBTL1KDM4EEPHX2 | |
| SCHEMBL6513820 | 0.81 | HCAR2 (0.41) | TSHRSMN1; SMN2LMNAL3MBTL1KDM4E | |
| SCHEMBL6515096 | 0.81 | TSHR (0.46) | TSHRRECQLNPC1RAB9ALMNA | |
| SCHEMBL6522180 | 0.80 | NLRP3 (0.41) | SMN1; SMN2LMNAL3MBTL1 | |
| SCHEMBL6516142 | 0.79 | TSHR (0.41) | TSHRRECQLNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL6519432 | 0.79 | FAAH (0.39) | TSHRLMNARARBHPGDL3MBTL1 | |
| SCHEMBL6515076 | 0.79 | DGKA (0.38) | TSHRLMNARARBHPGDEPHX2 | |
| SCHEMBL6518926 | 0.79 | FAAH (0.48) | TSHRRECQLLMNAFAAH | |
| SCHEMBL6520700 | 0.77 | TDP1 (0.44) | TSHRRECQLNPC1RAB9ALMNA | |
| SCHEMBL8812407 | 0.77 | HCAR2 (0.46) | TSHRHPGDKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | TSHR 3581/4885RECQL 2058/4885GPR88 2251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.